BETHESDA, Md., Hanger Orthopedic Group, Inc. (NYSE: HGR) has announced its
wholly-owned subsidiary Innovative Neurotronics, Inc. (IN, Inc.) received 510(k)
clearance from the U.S. Food and Drug Administration (FDA) to treat patients
with the WalkAide System®.
The first of IN, Inc.'s line of functional electrical stimulation products,
the WalkAide System is a medical device designed to counter the lack of ankle
dorsiflexion, commonly referred to as foot drop, in patients who have sustained
damage to upper motor neurons or pathways to the spinal cord. The WalkAide
System electrically stimulates the appropriate nerves and muscles. In addition
to improving the patient's gait, medical benefits of the WalkAide System may
include increased mobility, prevention/retardation of disuse atrophy, increased
local blood flow, muscle re-education, and maintained or increased joint range
"The commercial introduction of the WalkAide System will help us achieve our
vision of providing high technology products in the neuromuscular field by
leveraging Hanger s assets in distribution and patient care centers," Chairman
of the Board and Chief Executive Officer of Hanger Orthopedic Group, Inc. Ivan
R. Sabel, CPO said.
Hanger also announced today IN, Inc.'s newly-appointed management team, led
by President Jeff Martin.
"IN, Inc. has taken a significant step forward in its evolution by receiving
FDA approval and creating a management team with the talent and depth of
experience to advance our mission and expand the field of Myo-Orthotics
Technology®," Martin said.
The IN, Inc. management team includes:
Conrad Kufta, MD - As Chief Medical Officer, Kufta is responsible for the
overall clinical strategy for IN, Inc.'s products, which encompasses clinical
trials and protocols. A board certified neurosurgeon and foremost specialist in
the surgical treatment of epilepsy, Kufta previously served as Senior Staff
Neurosurgeon and Medical Officer in the Surgical Neurology Branch of the
National Institutes of Health (NIH) in Bethesda, Maryland and Senior Staff
Fellow in the Surgical Neurology Branch of the National Institute of
Neurological Disorders and Stroke (NINDS), a clinical and research Institute
within the NIH. A graduate of Georgetown University School of Medicine, Kufta
brings 35 years of medical experience to IN, Inc.
Joseph P. Moser - As Director of Product Development and Engineering, Moser
is responsible for development and engineering operations for all of IN, Inc.'s
current and future product lines, including oversight of design, validation,
characterization, and release to production. Having secured six U.S., four
Canadian, and many International patents, Moser has over 30 years engineering
experience specializing in the design and patenting of commercially viable
medical and consumer products. A 1975 graduate of the University of Michigan
with a Bachelor of Science in electrical engineering, Moser held numerous vice
president and director level positions at companies such as SnapShopper, Inc.,
Sabratek Corporation, and Information Resources, Inc.
Glen Neally - Director of Quality and Manufacturing
Pete Escallier - As Director of Marketing, Escallier is responsible for all
marketing programs and strategies. With a specialty in medical device marketing,
Escallier led the introduction of new products featuring proprietary technology
and managed existing products to higher levels of market share for companies
such as MiniMed / Medtronic, Applied Medical, CompuMed, American Hydro-Surgical,
and Edwards Life Sciences. A graduate of the University of Southern California,
Escallier has 28 years of marketing experience.
Mithu Rahman, MBA, PMP - Director of Technology Development and Support.
Karin Bolinger - Director of Reimbursement.
Mary-Kate Ennis, CO - As Director of Clinical Support, Ennis shares the
responsibility with Fish to establish, implement, and maintain all clinical
training and support clinical trials. A Certified Orthotist (CO), Ennis cared
for patients at Children s Healthcare of Atlanta and Connecticut Children's
Medical Center. She received her Master of Business Administration from Troy
State University, her Bachelor of Science in Physical and Health Education from
Norwich University, and her orthotics and prosthetics certificates from the
Newington Certificate Program.
About Hanger Orthopedic Group, Inc.:
Hanger Orthopedic Group,
Inc., headquartered in Bethesda, Maryland, is the world's premier provider of
orthotic and prosthetic patient care services. Hanger is the market leader in
the United States, owning and operating 618 patient care centers in 45 states
including the District of Columbia, with 3,405 employees including 1,017
practitioners. Hanger is organized into four units. The two key operating units
are patient care which consists of nationwide orthotic and prosthetic practice
centers and distribution which consists of distribution centers managing the
supply chain of orthotic and prosthetic componentry to Hanger and third party
patient care centers. The third is Linkia which is the first and only provider
network management company for the orthotics and prosthetics industry. The
fourth unit, Innovative Neurotronics, introduces emerging neuromuscular
technologies developed through independent research in a collaborative effort
with industry suppliers worldwide. For more information on Innovative
Neurotronics, Inc, visit www.ininc.us. For more information on Hanger, visit www.hanger.com.
Certain statements included in this press release are forward looking
statements within the meaning of the Private Securities Litigation Reform Act of
1995. Please refer to the Company's SEC filings for factors that could cause
actual results to differ materially from the Company's expectations.
Contact(s): Jason Owen, 301-986-0701, email@example.com
Media Contact(s): Jennifer
Bittner, 301-280-4869, firstname.lastname@example.org
SOURCE Hanger Orthopedic Group, Inc.
CONTACT: Investor Relations: Jason Owen, +1-301-986-0701,
Media: Jennifer Bittner, +1-301-280-4869,
of Hanger Orthopedic Group